ORUKA THERAPEUTICS INC (ORKA) Forecast, Price Target & Analyst Ratings

NASDAQ:ORKA • US6876041087

Current stock price

38.77 USD
-2.03 (-4.98%)
At close:
38.82 USD
+0.05 (+0.13%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ORUKA THERAPEUTICS INC (ORKA).

Forecast Snapshot

Consensus Price Target

Price Target
$57.98
+ 49.56% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 12, 2026
Period
Q4 / 2025
EPS Estimate
-$0.64
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
88.00%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$57.98
Upside
+ 49.56%
From current price of $38.77 to mean target of $57.98, Based on 20 analyst forecasts
Low
$40.40
Median
$57.12
High
$78.75

Price Target Revisions

1 Month
0.00%
3 Months
21.42%

Price Target Summary

20 Wall Street analysts provided a forecast for the next 12 months for ORKA. The average price target is 57.98 USD. This implies a price increase of 49.56% is expected in the next year compared to the current price of 38.77.
The average price target has been revised upward by 21.42% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

ORKA Current Analyst RatingORKA Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8

Analyst Ratings History

ORKA Historical Analyst RatingsORKA Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15

Analyst Ratings Consensus

ChartMill Buy Consensus
88.00%
ORKA was analyzed by 20 analysts. The buy percentage consensus is at 88. So analysts seem to be very confident about ORKA.
In the previous month the buy percentage consensus was at a similar level.
ORKA was analyzed by 20 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-16Leerink PartnersMaintains Outperform -> Outperform
2026-03-13GuggenheimReiterate Buy -> Buy
2026-03-13BTIGReiterate Buy -> Buy
2026-03-13StifelMaintains Buy -> Buy
2026-03-13BarclaysMaintains Overweight -> Overweight
2026-03-13WedbushReiterate Outperform -> Outperform
2026-01-13WedbushMaintains Outperform -> Outperform
2026-01-12BTIGMaintains Buy -> Buy
2026-01-07UBSInitiate Buy
2025-12-18Piper SandlerInitiate Overweight
2025-11-13BTIGMaintains Buy -> Buy
2025-11-13JefferiesInitiate Buy
2025-10-27GuggenheimInitiate Buy
2025-10-27HC Wainwright & Co.Maintains Buy -> Buy
2025-10-13BarclaysInitiate Overweight
2025-09-29BTIGReiterate Buy -> Buy
2025-09-17Clear StreetMaintains Buy -> Buy
2025-09-17BTIGMaintains Buy -> Buy
2025-08-18HC Wainwright & Co.Reiterate Buy -> Buy
2025-07-23HC Wainwright & Co.Reiterate Buy -> Buy
2025-05-15WedbushReiterate Outperform -> Outperform
2025-02-07HC Wainwright & Co.Reiterate Buy -> Buy
2025-02-04Wolfe ResearchInitiate Outperform
2024-12-20HC Wainwright & Co.Reiterate Buy -> Buy
2024-11-25HC Wainwright & Co.Reiterate Buy -> Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 12, 2026
Period
Q4 / 2025
EPS Estimate
-$0.64
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
-30.61%
Number of Analysts
14

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
1.49%

Next Earnings Summary

ORKA is expected to report earnings on 5/12/2026. The consensus EPS estimate for the next earnings is -0.64 USD and the consensus revenue estimate is 0 USD.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
ORKA revenue by date.ORKA revenue by date.
N/AN/AN/AN/AN/AN/AN/A
973.46%		N/A
282.14%		N/A
87.45%
EBITDA
YoY % growth
ORKA ebitda by date.ORKA ebitda by date.
-11.44M-16.59M
-45.02%		-18.68M
-12.60%		-8.1M
56.64%		-5.79M
28.52%		-9.76M
-68.57%		-19.319M
-97.94%		-10.576M
45.26%		-7.281M
31.16%		-88.096M
-1,109.94%		N/A
-42.07%		N/A
-21.46%		N/A
-7.42%		N/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
ORKA ebit by date.ORKA ebit by date.
-11.46M-16.61M
-44.94%		-18.71M
-12.64%		-8.12M
56.60%		-5.81M
28.45%		-9.77M
-68.16%		-19.335M
-97.90%		-10.596M
45.20%		-7.296M
31.14%		-88.123M
-1,107.83%		N/A
-43.07%		N/A
-25.84%		N/A
-24.45%		N/A
-34.69%		N/A
-24.20%		N/A
-22.40%		N/A
22.89%		N/A
150.90%		N/A
292.32%
Operating Margin
ORKA operating margin by date.ORKA operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
ORKA eps by date.ORKA eps by date.
N/AN/AN/A-120.96
71.85%		-54.36
55.06%		N/AN/AN/AN/AN/AN/A
37.39%		N/A
-19.03%		N/A
-8.28%		N/A
-23.94%		N/A
-12.98%		N/A
-11.68%		N/A
43.52%		N/A
236.21%		N/A
160.12%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		-0.64
-30.61%		-0.63
-57.08%		-0.66
-44.45%		-0.70
-26.54%		-0.68
-6.72%		-0.56
11.36%		-0.60
10.05%		-0.65
6.64%		-0.70
-2.90%
Revenue
Q2Q % growth		N/AN/AN/AN/A
EBITDA
Q2Q % growth		N/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-38.022M
-25.41%		-38.02M
-51.56%		-39.469M
-38.83%		-41.036M
-20.32%		-41.967M
-10.38%		N/AN/AN/AN/A

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

ORKA Yearly Revenue VS EstimatesORKA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2030 2031 2032 2033 500M 1B 1.5B
ORKA Yearly EPS VS EstimatesORKA Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 -100 -200 -300 -400

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
6.06%
EPS Next 5 Year
-2.48%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
-30.23%
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

ORUKA THERAPEUTICS INC / ORKA Forecast FAQ

Can you provide the average price target for ORUKA THERAPEUTICS INC stock?

20 analysts have analysed ORKA and the average price target is 57.98 USD. This implies a price increase of 49.56% is expected in the next year compared to the current price of 38.77.

What is the next earnings date for ORKA stock?

ORUKA THERAPEUTICS INC (ORKA) will report earnings on 2026-05-12.

What are the consensus estimates for ORKA stock next earnings?

The consensus EPS estimate for the next earnings of ORUKA THERAPEUTICS INC (ORKA) is -0.64 USD and the consensus revenue estimate is 0 USD.